Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:35 AM
Ignite Modification Date:
2025-12-25 @ 12:35 AM
NCT ID:
NCT04888767
Eligibility Criteria:
Inclusion Criteria:
* men and women aged over 18 years of age on the date of informed consent
* diagnosed CF patients
* not transplanted and not on the transplant waiting list
* able to participate in the proposed training programs (especially without cardiac contraindication)
* able to understand and respect the protocol and its requirement
* who signed the consent prior to any other procedure protocol
Exclusion Criteria:
* major patients under guardianship / curatorship / legal protection
* pregnant patients
* dialysis patients
* patients with a severe exacerbation at the time of inclusion
* patients for whom a new modulating treatment (eg.: Kaftrio®, Kalydeco®, Symkevi®, etc.) has been implemented in the 4 weeks preceding inclusion
* patients with pulmonary arterial hypertension (≥ 25 mmHg)
* patients unable to complete the entire program
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04888767
Study Brief:
Protocol Section:
NCT04888767